Bioengineered optogenetic model of human neuromuscular junction

Area of Science:

• Biomedical Engineering
• Stem Cell Technology
• Neuroscience

Background:

• Patient-specific induced pluripotent stem cells (hiPSCs) offer potential for disease modeling in musculoskeletal disorders.
• Existing methods for engineering complex tissues like innervated skeletal muscle lack standardization, hindering reproducibility and predictive power.
• There is a critical need for objective, quantitative methods to study human neuromuscular junction (NMJ) development and function.

Purpose of the Study:

• To develop a standardized method for engineering patient-specific human neuromuscular junctions (NMJs).
• To create a platform for automated quantification of NMJ function.
• To enable disease diagnosis and evaluation of therapeutic strategies using engineered NMJs.

Main Methods:

• Combined tissue engineering, optogenetics, microfabrication, optoelectronics, and video processing.
• Engineered an isogenic, patient-specific human NMJ model.
• Developed automated quantification of NMJ function.

Main Results:

• Successfully created a novel platform for precise investigation of human NMJ development and degeneration.
• Demonstrated automated quantification of NMJ function.
• Showcased the platform's utility in detecting and diagnosing myasthenia gravis.

Conclusions:

• The developed standardized method and platform enhance the robustness, reproducibility, and predictability of engineered human tissues.
• This approach facilitates the identification of novel therapeutic targets for musculoskeletal and neurological disorders.
• The platform provides a powerful tool for diagnosing diseases like myasthenia gravis and evaluating potential treatments.